Clin2
NCT07460518Possibly a fitRecruiting

Tranexamic acid for reducing bleeding during prostate surgery

Benign Prostatic HyperplasiaTransurethral Resection of the ProstatePerioperative BleedingAnemia, Postoperative

Treatments studied

Part of Blood & lymphatic, Kidney & urinary clinical trials.

This trial tests whether a medicine called tranexamic acid, given during surgery to remove part of the prostate, can reduce bleeding. If you are scheduled for this type of prostate surgery, this treatment might help make the procedure safer and improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
80 people
Ages
50 years and older
Study type
Interventional

Who can take part

  • Be a man aged 50 or older
  • Have an enlarged prostate (BPH) and be scheduled for TURP surgery under spinal anesthesia
  • Have no history of blood clots, stroke, or seizures
  • Have normal or only mildly reduced kidney function
  • Not be currently taking blood thinners that haven't been stopped before surgery (as directed by your doctor)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06710327Not yet recruiting· Phase 4
Tranexamic acid to reduce bleeding during aquablation for enlarged prostate

This study tests whether giving a medicine called tranexamic acid before Aquablation surgery helps reduce bleeding during the procedure. The goal is to see if it makes the surgery safer and reduces blood loss for men with an enlarged prostate.

Los Angeles, California
NCT07501884Not yet recruiting· Phase 4
Medication to reduce bleeding during urethral surgery

This study tests whether a medicine called tranexamic acid (TXA) can reduce bleeding during urethroplasty surgery. If it works, it may help you recover with fewer complications.

Newark, New Jersey
NCT04312880Enrolling by invitation· Phase 4
Tranexamic acid during elective back surgery to reduce bleeding

This trial studies whether giving tranexamic acid (a medicine that helps reduce bleeding) during planned lower-back decompression surgery can lower blood loss or related complications. It compares patients who receive the infusion during surgery to those who meet study procedures and safety requirements.

Albany, New York
NCT02314988Recruiting· Phase 2/Phase 3
Tranexamic acid to reduce bleeding in spine surgery

This trial tests whether tranexamic acid (a medicine that helps blood clot) can reduce blood loss during long spine surgery after an injury. It may help lower the chance of needing transfusions and manage surgical bleeding.

San Francisco, California
NCT06657924Recruiting· Phase 2
TXA to Prevent Bleeding in Colorectal Surgery

This trial tests a medicine called tranexamic acid (TXA) given right before major colorectal surgery to see if it helps reduce bleeding. If it works, it could make surgery safer for people like you.

Cleveland, Ohio
NCT03553186Recruiting· Phase 3
Tranexamic acid to reduce bleeding in spine surgery

This Phase 3 trial tests whether tranexamic acid can reduce bleeding during major spine fusion surgery for adults with scoliosis or spine degeneration. It may help lessen blood loss and the need for transfusions, while monitoring safety.

New York, New York

Hear when a new Benign Prostatic Hyperplasia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.